Results 191 to 200 of about 105,245 (307)

Development of a Clinical Severity Score for Indian Sickle Cell Anaemia Patients. [PDF]

EJHaem
Nongmaithem SS, Biswas A, Iyer S, Vyshnavi J, Wath A, Chandak GR, Jain D.   +6 more
europepmc   +1 more source

Increased vancomycin dosing requirements in sickle cell disease due to hyperfiltration-dependent and independent pathways

Haematologica, 2017
Jin Han, Xu Zhang, Jennifer Oderinde, Santosh L. Saraf, Michel Gowhari, Joharah Hassan, Shivi Jain, Victor R. Gordeuk, Robert E. Molokie   +8 more
doaj   +1 more source

Mitapivat for sickle cell disease: the time is ripe for a new therapy. [PDF]

Ann Transl Med
Cheng AN, Al-Samkari H.
europepmc   +1 more source

Pediatric transfusion camp: Developing, piloting and evaluation of a Canadian national pediatric transfusion medicine curriculum

Transfusion, EarlyView.
Abstract Background Standardized post‐graduate education in pediatric transfusion medicine remains limited. The objective of this study was to adapt an adult transfusion education program, Transfusion Camp, to include pediatric content and assess knowledge improvement in pediatric subspecialty trainees.
Ines Zuna, Valérie Arsenault, Kimmo Murto, Suzanne Beno, MacGregor Steele, Jennifer Young, Sarah Leir, Angela Punnett, Cheryl Peters, Lucille Barcat, Yulia Lin, Casey Kapitany, Sophie Chargé, Teresa Skelton, Lani Lieberman   +14 more
wiley   +1 more source

Circulating erythropoietin concentration associates with thromboembolism in sickle cell disease. [PDF]

Br J Haematol
Zhang X, Shah BN, Han J, Nouraie M, Zhang Y, Machado RF, Gladwin MT, Saraf SL, Gordeuk VR.   +8 more
europepmc   +1 more source

International multicentre evaluation of a new anti‐idiotypic anti‐daratumumab for resolving pre‐transfusion interferences

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Daratumumab, a therapeutic human anti‐CD38 monoclonal antibody, improves multiple myeloma outcomes but interferes with pre‐transfusion testing by binding CD38 on reagent red blood cells (RBCs), potentially masking clinically significant alloantibodies.
Arnaud Reggiani, Sofia Lejon Crottet, Sophie Waldvogel, Charlotte Engström, Serelina Coluzzi, Antonella Matteocci, Janis R. Hamilton, Levent Tufan Kumas, Karen M. K. de Vooght, Jill R. Storry, Jennylyn Flores, Núria Nogués, Carlos Cotorruelo, Molly Rutherford, Eveline B. Nilsen, Monika Pelc‐Kłopotowska, Jolanta Korzeniowska, Alessandra Baffa, Inna Sareneva, Nor Hafizah Ahmad, Katarzyna Szczudlo, Athif Rahman, Laser Sanal, Lise Jørgensen, Karolina Majewska Rochowiak, Monika Salwierz, Elisaveta Grancharova, Bojana Zivkovic, Jessica Alvarez, Mareike Riedl, Achim Knappik   +30 more
wiley   +1 more source

Transthyretin V122I variant and protein affect cardiac severity and mortality in sickle cell disease. [PDF]

Blood Adv
Li H, Gao S, Wang X, Asomaning N, Conrey A, Kruah B, Joo J, Wu CO, Sachdev V, Thein SL.   +9 more
europepmc   +1 more source

What you should know about sickle cell trait [French]

What you should know about sickle cell trait [French]Le trait dr\ue9panocytaire (SCT) n\u2019est pas une forme l\ue9g\ue8re de dr\ue9panocytose.

core  

Molecular characterization of D variants in Brazilian blood donors and their association with RhCE and Duffy phenotypes

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Serological classification of RhD‐negative and weak D is often insufficient in admixed populations, where diverse RHD variants have clinical implications. In Brazil's highly admixed population, RhD interpretation and donor–recipient matching are particularly challenging.
Thamy C. S. Silva, Marcia R. Dezan, Sidneia Costa, Beatriz C. Girardo, Bruno R. Cruz, Karen Ziza, Dante M. Langhi, José O. Bordin, Lilian Castilho, Carla L. Dinardo   +9 more
wiley   +1 more source

A maximal-coverage approach to prioritizing newborn sickle cell screening sites in Uganda using a sickle cell-malaria co-risk surface. [PDF]

Malar J
Paasi G, Ndeezi G, Kiyaga C, Namazzi R, Mupere E, Munabi IG, Kiguli S, Idro R, Olupot-Olupot P.   +8 more
europepmc   +1 more source